Design
Review
Authors
Loading...
May inform calcium antagonist selection by chemical properties; leaves open need for comparative outcome trials.
Provides an overview of calcium-antagonist drugs and their chemical heterogeneity in the treatment of cardiovascular disease.
Flier et al. (1985) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: